EcoDrugPlus

Myeloperoxidase

Ensembl ID : ENSPLOG00000013335
Gene Symbol: MPO
4 Cross references
181 Possible Orthologues:

Natriuretic Peptide Receptor 1

Ensembl ID : ENSPLOG00000010004
Gene Symbol: NPR1
2 Cross references
184 Possible Orthologues:

Natriuretic Peptide Receptor 2

Ensembl ID : ENSPLOG00000013537
Gene Symbol: NPR2
4 Cross references
259 Possible Orthologues:

Natriuretic Peptide Receptor 3

Ensembl ID : ENSPLOG00000015454
Gene Symbol: NPR3
4 Cross references
211 Possible Orthologues:

Neuropeptide Y Receptor Y2

Ensembl ID : ENSPLOG00000007048
Gene Symbol: NPY2R
4 Cross references
246 Possible Orthologues:

Neuropeptide Y Receptor Y4-2

Ensembl ID : ENSPLOG00000021298
Gene Symbol: NPY4R2
3 Cross references
116 Possible Orthologues:

Neuropeptide Y Receptor Y5

Ensembl ID : ENSPLOG00000002960
Gene Symbol: NPY5R
4 Cross references
135 Possible Orthologues:

Neurotensin Receptor 1

Ensembl ID : ENSPLOG00000015983
Gene Symbol: NTSR1
2 Cross references
211 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 1

Ensembl ID : ENSPLOG00000022302
Gene Symbol: NTRK1
2 Cross references
199 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 2

Ensembl ID : ENSPLOG00000012890
Gene Symbol: NTRK2
4 Cross references
286 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 3

Ensembl ID : ENSPLOG00000022128
Gene Symbol: NTRK3
4 Cross references
269 Possible Orthologues:

Nicastrin

Ensembl ID : ENSPLOG00000017121
Gene Symbol: NCSTN
4 Cross references
203 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).